Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label studyGrant A. McArthur, Axel Hauschild, Antoni Ribas et al.|The Lancet Oncology|2014Cited by 978
Alanine for Proline Substitution in the Peroxisome Proliferator–Activated Receptor Gamma-2 (PPARG2) Gene and the Risk of Incident Myocardial InfarctionPaul M. Ridker, Robert Y.L. Zee, Nancy R. Cook et al.|Arteriosclerosis Thrombosis and Vascular Biology|2003Cited by 101
A Meta-Analysis of Candidate Gene Polymorphisms and Ischemic Stroke in 6 Study PopulationsXingyu Wang, Nancy R. Cook, Suzanne Cheng et al.|Stroke|2009Cited by 85